CPT1A plays a key role in the development and treatment of multiple sclerosis and experimental autoimmune encephalomyelitis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CPT1A plays a key role in the development and treatment of multiple sclerosis and experimental autoimmune encephalomyelitis
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-16
DOI
10.1038/s41598-019-49868-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives
- (2018) Fengna Chu et al. MEDIATORS OF INFLAMMATION
- Multiple Sclerosis: Mechanisms and Immunotherapy
- (2018) Clare Baecher-Allan et al. NEURON
- Identification of brain antigens recognized by autoantibodies in experimental autoimmune encephalomyelitis-induced animals treated with etomoxir or interferon-β
- (2018) Anne Skøttrup Mørkholt et al. Scientific Reports
- Neuronal Lipid Metabolism: Multiple Pathways Driving Functional Outcomes in Health and Disease
- (2018) Timothy J. Tracey et al. Frontiers in Molecular Neuroscience
- The novel Nrf2 inducer TFM-735 ameliorates experimental autoimmune encephalomyelitis in mice
- (2017) Chika Higashi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Fats for thoughts: An update on brain fatty acid metabolism
- (2017) Adele Romano et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Blocking of carnitine palmitoyl transferase 1 potently reduces stress-induced depression in rat highlighting a pivotal role of lipid metabolism
- (2017) Anne Skøttrup Mørkholt et al. Scientific Reports
- The Inuit gut microbiome is dynamic over time and shaped by traditional foods
- (2017) Geneviève Dubois et al. Microbiome
- Gut Microbiome of the Canadian Arctic Inuit
- (2017) Catherine Girard et al. mSphere
- Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine
- (2015) Aiden Haghikia et al. IMMUNITY
- Inhibition of NADPH oxidase activation reduces EAE-induced white matter damage in mice
- (2015) Bo Young Choi et al. Journal of Neuroinflammation
- A Selective Sweep on a Deleterious Mutation in CPT1A in Arctic Populations
- (2014) Florian J. Clemente et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Immunolocalization of Water Channel Proteins AQP1 and AQP4 in Rat Spinal Cord
- (2014) Michal K. Oklinski et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
- (2014) Manuel A. Friese et al. Nature Reviews Neurology
- Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis
- (2014) Philip G Nijland et al. Acta Neuropathologica Communications
- Interactions between inflammation and lipid metabolism: Relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis
- (2013) Janna A. van Diepen et al. ATHEROSCLEROSIS
- High Fat Diet Exacerbates Neuroinflammation in an Animal Model of Multiple Sclerosis by Activation of the Renin Angiotensin System
- (2013) Silke Timmermans et al. Journal of Neuroimmune Pharmacology
- Association of a Genetic Variant of Carnitine Palmitoyltransferase 1A with Infections in Alaska Native Children
- (2013) Bradford D. Gessner et al. JOURNAL OF PEDIATRICS
- Fueling and Imaging Brain Activation
- (2012) Gerald A Dienel ASN Neuro
- Characteristics of multiple sclerosis in aboriginals living in British Columbia, Canada
- (2012) Jameelah Saeedi et al. Multiple Sclerosis Journal
- Biochemistry meets biology: key findings for bone calcification and a lifetime philosophy of collaboration
- (2011) Gillian Murphy et al. BIOCHEMICAL JOURNAL
- Multiple Sclerosis: Pathogenesis and Treatment
- (2011) Ingrid Loma et al. Current Neuropharmacology
- Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
- (2011) R. D. Michalek et al. JOURNAL OF IMMUNOLOGY
- Multiple Sclerosis is Not a Disease of the Immune System
- (2011) Angelique P. Corthals QUARTERLY REVIEW OF BIOLOGY
- Inhibition of fatty acid metabolism ameliorates disease activity in an animal model of multiple sclerosis
- (2011) Leah P. Shriver et al. Scientific Reports
- A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation
- (2010) Sander Michel Houten et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Carnitine palmitoyltransferase 1A (CPT1A) P479L prevalence in live newborns in Yukon, Northwest Territories, and Nunavut
- (2010) Sorcha A. Collins et al. MOLECULAR GENETICS AND METABOLISM
- Is multiple sclerosis a mitochondrial disease?
- (2009) Peizhong Mao et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Carnitine palmitoyltransferase IA polymorphism P479L is common in Greenland Inuit and is associated with elevated plasma apolipoprotein A-I
- (2009) Chandheeb Rajakumar et al. JOURNAL OF LIPID RESEARCH
- The paradox of the carnitine palmitoyltransferase type Ia P479L variant in Canadian Aboriginal populations
- (2009) Cheryl R. Greenberg et al. MOLECULAR GENETICS AND METABOLISM
- Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
- (2008) Bruce D. Trapp et al. Annual Review of Neuroscience
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started